AI Terminal
ECO ANIMAL HEALTH GROUP PLC
Declaration of Voting Results & Voting Rights Announcements • Sep 27, 2024
7612_dva_2024-09-27_d74642f7-1da0-4d72-9e22-5cd1e15299fd.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0770G
Eco Animal Health Group PLC
27 September 2024
27 September 2024
ECO Animal Health Group plc
("ECO" or the "Company")
Result of Annual General Meeting
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that at its Annual General Meeting held yesterday all resolutions proposed to the meeting were duly passed.
Votes received in relation to each resolution were as follows:
| Resolution | For | % | Discretionary | % | Against | % |
| 01 | 41,070,268 | 100.00 | Nil | 0.00 | Nil | 0.000 |
| 02 | 36,456,852 | 88.768 | Nil | 0.00 | 4,613,165 | 11.232 |
| 03 | 40,961,390 | 99.735 | Nil | 0.00 | 108,878 | 0.265 |
| 04 | 34,395,129 | 84.081 | Nil | 0.00 | 6,511,866* | 15.919 |
| 05 | 41,070,404 | 99.999 | Nil | 0.00 | 541 | 0.001 |
| 06 | 40,976,766 | 99.771 | Nil | 0.00 | 94,179 | 0.229 |
| 07 | 40,945,821 | 99.709 | 784 | 0.002 | 118,663 | 0.289 |
| 08 | 40,957,821 | 99.726 | 784 | 0.002 | 111,663 | 0.272 |
| 09 | 41,046,763 | 99.941 | 7,500 | 0.018 | 16,682 | 0.041 |
* Note: The Board has been informed that a shareholder holding a block of 1,902,729 votes incorrectly lodged a proxy in respect of these shares against resolution 4. This shareholder acknowledged that the intent had been to vote these shares in favour of resolution 4.
-Ends-
For further information please contact:
| ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO) |
020 8447 8899 |
| Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher |
020 7496 3000 |
| Investec (Joint Broker) Gary Clarence Lydia Zychowska |
020 7597 5970 |
| Equity Development Hannah Crowe Matt Evans |
020 7065 2692 |
| ICR Consilium (Financial PR) Mary-Jane Elliott Jessica Hodgson |
020 3709 5700 [email protected] |
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGSEUFDWELSEFU